• English
  • Français
Bladder Cancer CanadaBladder Cancer CanadaBladder Cancer CanadaBladder Cancer Canada
  • Bladder Cancer
    • See Red?
    • What is Bladder Cancer?
    • Statistics and Risk Factors
    • Symptoms and Diagnosis
    • Staging and Grading
    • Types of Bladder Cancer
      • Non-Muscle Invasive Bladder Cancer
      • Muscle Invasive Bladder Cancer
      • Metastatic Bladder Cancer
      • Upper Tract Urothelial Carcinoma
    • Treatment Options
      • TURBT
      • BCG
      • Chemotherapy and Radiation
      • Bladder Removal
      • Immunotherapy
      • Bladder Preservation Options
      • Palliative Care
      • Clinical Trials
      • Advanced Bladder Cancer Treatment
    • Research and Studies
  • Patients
    • Get Support
      • Support Groups
      • One2One Peer Support
      • Online Discussion Forum
      • Contact Us by Phone or Email
    • Navigating Your Diagnosis
      • Newly Diagnosed?
      • Coping With Emotions
      • Health and Wellness Resources
      • Clinical Trials
    • Educational Resources
      • Guidebooks
      • Webinars and Videos
      • Podcast
      • Newsletter
      • Glossary
    • Upcoming Events
    • News and Stories
    • Links and Other Resources
  • Get Involved
    • Donate
    • Fundraise
    • Volunteer
    • Share Your Story
    • Patient Study Recruitment
    • Patient Self-Advocacy
    • Bladder Cancer Awareness Month
    • Your Impact
  • Health Care Practitioners
    • Doctor Resources
    • BCC Research Grant Applications
    • BCC Research Grant Recipients
    • CBCIS
    • CBCRN
    • Medical Advisory Board
  • About Us
    • Who We Are
    • Board of Directors
    • Staff
    • Medical Advisory Board
    • Sponsors and Partners
    • Financial Statements and Annual Reports
    • Newsletter
    • Contact Us
  • Walk With Us
  • Donate
NextPrevious

Bladder cancer doesn’t discriminate when it comes to age

By Bladder Cancer Canada | Latest news and stories | 6 June, 2022 | 0

By Rob Truscott

Like many bladder cancer patients, Julie has a unique story.  She met virtually with Tawny Barratt, Bladder Cancer Canada’s (BCC) Director of Communications to tell her story.  This story highlights many concerns of patients, and the BCC team, but most of all – it shows how we must all be vigilant.

Julie is a patient that is well outside the normal demographics, and it showed through in the initial parts of her bladder cancer journey.  Initially diagnosed at 22 years old in December of 1994, she approaches 28 years of dealing with the impacts of bladder cancer.

Outside of that surprise, was that her father was diagnosed with bladder cancer mere months before, at the age of 56.  That lead to increased knowledge of bladder cancer when the discussions with doctors began.  Her symptoms were limited to blood in her urine, which was the opposite of her dad’s symptoms, which included pain and frequent urination.

Since she didn’t fit the typical bladder cancer profile (young female vs older male), her doctors were hesitant to consider bladder cancer and believed it was a recurring Urinary Tract Infection (UTI) that they treated with antibiotics for a few months.  Her urologist was not willing to consider bladder cancer, thinking it might be part of her menstrual cycle but was finally convinced that a cystoscopy should be performed.  That’s when life changed, when the surprised urologist discovered a tumour the size of a golf ball.

Julie was diagnosed with a T1, non-muscle invasive bladder cancer, before it had a chance to move into the bladder wall.  Early in 1995, the first surgery was performed. 

Bladder cancer is known for its recurrences, and Julie has stopped counting the number of times (at 30) a cystoscopy has shown her a collection of tumours in her bladder that shouldn’t be there, which are subsequently removed.

Part of the discussion with Julie is about the many life changes that she has undergone.  Realizing that she has been dealing with bladder cancer more than half her life, through having kids, raising kids, and a demanding job.  This includes tumours being burned out without anesthetic while she was pregnant.

She talks about many lifestyle changes that included many adjustments in products she uses in everyday life, her eating habits, and how these changes have not seemed to have a connected impact to the time span between tumour regrowth.  Julie has maintained employment through these years, and talks about her time off from work.

Listen to the accompanying podcast to hear Julie talk about her experiences and reminds listeners of the following:

1.  If you see red, see your doctor

2.  If you are not happy with what they say, and if you feel you are being dismissed – advocate for proper testing.

3.  There is no specific reason to why you might be diagnosed with bladder cancer, and

4.  You can lead a fulfilling life, even if you have this disease.

Julies last surgery was in June of 2021, with her last cystoscopy in November 2021, and again in April 2021, with no tumour recurrences noted.  We wish her all the best in the future.

There are currently 80,000 Canadians living with a bladder cancer diagnosis and 12,000 more will be diagnosed this year. At Bladder Cancer Canada, we are doing everything we can to increase awareness of this devastating disease to as many Canadians as possible – including this podcast that we created for Bladder Cancer Awareness Month.

Bladder Cancer Canada’s mission is simple: To support patients, increase awareness, and fund research. Please join us in making our vision a reality – a world where bladder cancer is just a memory. If you enjoyed today’s blog/podcast, help us make a difference – please consider making a donation today. 

We commit to using all funds in a responsible and transparent way, ensuring that your donation helps people in their fight against bladder cancer.

Listen to the podcast on Buzzsprout here or on Spotify here.

This podcast/blog is generously sponsored by Bristol Myers Squibb, Pfizer Canada and EMD Serono. 

Donate Today

No tags.

Related Post

  • Volunteer’s personal approach leads to deeper commitment from corporate supporter

    By Bladder Cancer Canada | 0 comment

    By: Tom Eremondi Read time: 3.5 minutes Admittedly old school, Gerry Ross’ approach to dealing with a local walk sponsor nurtured and enhanced the relationship to a surprising level. This story, however, dates back aboutRead more

  • “The risk of recurrence of my cancer is high, so I need to take care of myself.”

    By Bladder Cancer Canada | 0 comment

    Read time: 2 minutes We were so pleased to see one of our new Peer Support Volunteers, Gervais  Fournier, featured in this New Normal, Same Cancer news story, seen last month in the Le JournalRead more

  • This May, we’re making bladder cancer impossible to ignore! 

    By Bladder Cancer Canada | Comments are Closed

    Subscribe today! Our May newsletter is filled with lots of initiatives to create awareness for bladder cancer including blogs, podcasts, helpful facts, webinars and more. Bladder cancer is the 5th most common cancer in Canada andRead more

  • Bladder cancer & COVID-19 FAQ

    By Bladder Cancer Canada | Comments are Closed

    Uncertain times are upon us, around the world, as we globally respond to the coronavirus (COVID-19) that is affecting us all on some level. Many members of our bladder cancer community are directing questions our way aboutRead more

  • Protecting Yourself During the Coronavirus Outbreak

    By Bladder Cancer Canada | Comments are Closed

    (The following content is sourced from various sites advising on the coronavirus. For more information, please see the end of this article for additional resources. Photo Credit: CDC) As news of the coronavirus (COVID-19) continues toRead more

  • Health Canada Approves BALVERSA

    By Bladder Cancer Canada | Comments are Closed

    In a recent press release, Janssen Pharmaceutical Companies of Johnson & Johnson have announced that they have received approval from Health Canada for BALVERSA™ (erdafitinib), the first FGFR Kinase inhibitor for the treatment of patientsRead more

  • Announcing the Launch of Our New Hematuria Brochure: A Vital Resource for Early Bladder Cancer Detection 

    By Bladder Cancer Canada | Comments are Closed

    We have developed this easy-to-understand resource aimed at increasing awareness of hematuria.

  • Our First Annual Research Report Is Live! 

    By Bladder Cancer Canada | Comments are Closed

    Our first Annual Research Report brings you exciting updates from the world of bladder cancer research.

  • Tax Season is Upon Us! 

    By Bladder Cancer Canada | Comments are Closed

    Spring has sprung and so has tax season! Don’t miss out on valuable credits or deductions! 

  • Happy National Volunteer Week 2025!

    By Bladder Cancer Canada | Comments are Closed

    National Volunteer Week is celebrated annually to honour all the volunteers who make a powerful impact.

  • Patient Story: Stéphanie

    By Bladder Cancer Canada | Comments are Closed

    My life turned upside down with the announcement of a bladder cancer diagnosis.

Leave a Comment

Cancel reply

Your email address will not be published. Required fields are marked *

NextPrevious

Recent Blog Posts

  • Announcing the Launch of Our New Hematuria Brochure: A Vital Resource for Early Bladder Cancer Detection 
  • Our First Annual Research Report Is Live! 
  • Economic Impacts of a Cancer Diagnosis on Canadians
  • Tax Season is Upon Us! 
  • Happy National Volunteer Week 2025!

Upcoming Events

  • Outreach Events
  • In-person Education Events
  • Support Groups
  • Webinars

Blog Categories

  • Blog
  • Honouring our volunteers
  • Latest news and stories
  • Patient Stories
  • Upcoming meeting and events
  • Volunteers
  • Webinar

Bladder Cancer Canada

4936 Yonge Street, Suite 1000, Toronto, ON M2N 6S3
Phone: 1-866-674-8889
Email & Media Contact: info@bladdercancercanada.org

Privacy Policy | Donor Bill of Rights

Charitable Reg No. 83612 6060 RR0001

© Bladder Cancer Canada.

SUBSCRIBE TO OUR NEWSLETTER
SEND US A MESSAGE
  • Bladder Cancer
    • See Red?
    • What is Bladder Cancer?
    • Statistics and Risk Factors
    • Symptoms and Diagnosis
    • Staging and Grading
    • Types of Bladder Cancer
      • Non-Muscle Invasive Bladder Cancer
      • Muscle Invasive Bladder Cancer
      • Metastatic Bladder Cancer
      • Upper Tract Urothelial Carcinoma
    • Treatment Options
      • TURBT
      • BCG
      • Chemotherapy and Radiation
      • Bladder Removal
      • Immunotherapy
      • Bladder Preservation Options
      • Palliative Care
      • Clinical Trials
      • Advanced Bladder Cancer Treatment
    • Research and Studies
  • Patients
    • Get Support
      • Support Groups
      • One2One Peer Support
      • Online Discussion Forum
      • Contact Us by Phone or Email
    • Navigating Your Diagnosis
      • Newly Diagnosed?
      • Coping With Emotions
      • Health and Wellness Resources
      • Clinical Trials
    • Educational Resources
      • Guidebooks
      • Webinars and Videos
      • Podcast
      • Newsletter
      • Glossary
    • Upcoming Events
    • News and Stories
    • Links and Other Resources
  • Get Involved
    • Donate
    • Fundraise
    • Volunteer
    • Share Your Story
    • Patient Study Recruitment
    • Patient Self-Advocacy
    • Bladder Cancer Awareness Month
    • Your Impact
  • Health Care Practitioners
    • Doctor Resources
    • BCC Research Grant Applications
    • BCC Research Grant Recipients
    • CBCIS
    • CBCRN
    • Medical Advisory Board
  • About Us
    • Who We Are
    • Board of Directors
    • Staff
    • Medical Advisory Board
    • Sponsors and Partners
    • Financial Statements and Annual Reports
    • Newsletter
    • Contact Us
  • Walk With Us
  • Donate
Bladder Cancer Canada